In vivo performance of polymer nanocarriers dually-targeted to epitopes of the same or different receptors

Biomaterials

Volumn 34, Issue 13, 2013, Pages 3459-3466

  Papademetriou, Iason T ^a   Garnacho, Carmen ^b   Schuchman, Edward H ^c   Muro, Silvia ^a,d  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF SEVILLE   (Spain)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

Author keywords

Combination targeting; ICAM 1; In vivo biodistribution; Multiple epitopes; Multivalent nanocarriers; Transferrin receptor

Indexed keywords

COMBINATION TARGETING; ICAM-1; IN-VIVO; NANO-CARRIERS; TRANSFERRIN RECEPTORS;

ANTIBODIES; CELL ADHESION; CELL MEMBRANES; DRUG DELIVERY; ENZYMES; MOLECULES; NANOSTRUCTURED MATERIALS; PLASTIC COATINGS;

EPITOPES;

CELL RECEPTOR; EPITOPE; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; MONOCLONAL ANTIBODY; NANOCARRIER; POLYMER; SPHINGOMYELIN PHOSPHODIESTERASE; TRANSFERRIN RECEPTOR; TRANSFERRIN RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN; CHEMICAL MODIFICATION; COMBINATION DRUG TARGETING; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG SPECIFICITY; DRUG TARGETING; IN VIVO STUDY; LIVER; LUNG; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE SPECIFICITY;

ANIMALS; ANTIBODIES; BRAIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EPITOPES; INTERCELLULAR ADHESION MOLECULE-1; MALE; MICE; MICE, INBRED C57BL; NANOPARTICLES; ORGAN SPECIFICITY; POLYMERS; RECEPTORS, TRANSFERRIN; SPHINGOMYELIN PHOSPHODIESTERASE; TISSUE DISTRIBUTION;

MUS;

EID: 84874253580     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.01.069     Document Type: Article

References (55)

1. Allen T.M., Cullis P.R. Drug delivery systems: entering the mainstream. Science 2004, 303:1818-1822.
2. Torchilin V.P. Drug targeting. Eur J Pharm Sci 2000, 11(Suppl. 2):S81-S91.
3. Muro S., Koval M., Muzykantov V. Endothelial endocytic pathways: gates for vascular drug delivery. Curr Vasc Pharmacol 2004, 2:281-299.
4. Muro S. Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders. Drug Deliv Transl Res 2012, 2:169-186.
5. Chrastina A., Massey K.A., Schnitzer J.E. Overcoming in vivo barriers to targeted nanodelivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011, 3:421-437.
6. Muro S. Challenges in design and characterization of ligand-targeted drug delivery systems. J Control Release 2012, 164:125-137.
7. Smith C.W. 3. Adhesion molecules and receptors. J Allergy Clin Immunol 2008, 121:S375-S379. quiz S414.
8. Grove J, Marsh M. The cell biology of receptor-mediated virus entry. J Cell Biol;195:1071-82.
9. Robbins G.P., Saunders R.L., Haun J.B., Rawson J., Therien M.J., Hammer D.A. Tunable leuko-polymersomes that adhere specifically to inflammatory markers. Langmuir 2010, 26:14089-14096.
10. Gunawan R.C., Almeda D., Auguste D.T. Complementary targeting of liposomes to IL-1 alpha and TNF-alpha activated endothelial cells via the transient expression of VCAM-1 and E-selectin. Biomaterials 2011, 32:9848-9853.
11. Ferrante E.A., Pickard J.E., Rychak J., Klibanov A., Ley K. Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow. J Control Release 2009, 140:100-107.
12. Eniola A.O., Willcox P.J., Hammer D.A. Interplay between rolling and firm adhesion elucidated with a cell-free system engineered with two distinct receptor-ligand pairs. Biophys J 2003, 85:2720-2731.
13. McAteer M.A., Schneider J.E., Ali Z.A., Warrick N., Bursill C.A., von zur Muhlen C., et al. Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide. Arterioscler Thromb Vasc Biol 2008, 28:77-83.
14. Weller G.E., Villanueva F.S., Tom E.M., Wagner W.R. Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl lewisx. Biotechnol Bioeng 2005, 92:780-788.
15. Ying X, Wen H, Lu WL, Du J, Guo J, Tian W, et al. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. J Control Release;141:183-92.
16. Zhang Y., Zhu C., Pardridge W.M. Antisense gene therapy of brain cancer with an artificial virus gene delivery system. Mol Ther 2002, 6:67-72.
17. Chacko A.M., Nayak M., Greineder C.F., Delisser H.M., Muzykantov V.R. Collaborative enhancement of antibody binding to distinct PECAM-1 epitopes modulates endothelial targeting. PloS One 2012, 7:e34958.
18. Garnacho C., Albelda S.M., Muzykantov V.R., Muro S. Differential intra-endothelial delivery of polymer nanocarriers targeted to distinct PECAM-1 epitopes. J Control Release 2008, 130:226-233.
19. Balyasnikova I.V., Metzger R., Visintine D.J., Dimasius V., Sun Z.L., Berestetskaya Y.V., et al. Selective rat lung endothelial targeting with a new set of monoclonal antibodies to angiotensin I-converting enzyme. Pulm Pharmacol Ther 2005, 18:251-267.
20. Balyasnikova I.V., Karran E.H., Albrecht R.F., Danilov S.M. Epitope-specific antibody-induced cleavage of angiotensin-converting enzyme from the cell surface. Biochem J 2002, 362:585-595.
21. Lee H.J., Engelhardt B., Lesley J., Bickel U., Pardridge W.M. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse. J Pharmacol Exp Ther 2000, 292:1048-1052.
22. Daniels T.R., Bernabeu E., Rodriguez J.A., Patel S., Kozman M., Chiappetta D.A., et al. The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochim Biophys Acta 1820, 291-317.
23. Boado R.J., Zhang Y., Wang Y., Pardridge W.M. Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood-brain barrier delivery in the mouse. Biotechnol Bioeng 2009, 102:1251-1258.
24. Zhou QH, Boado RJ, Lu JZ, Hui EK, Pardridge WM. Brain-penetrating IgG-iduronate 2-sulfatase fusion protein for the mouse. Drug Metab Dispos;40:329-35.
25. Ko Y.T., Bhattacharya R., Bickel U. Liposome encapsulated polyethylenimine/odn polyplexes for brain targeting. J Control Release 2009, 133:230-237.
26. van Rooy I, Mastrobattista E, Storm G, Hennink WE, Schiffelers RM. Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain. J Control Release;150:30-6.
27. Hatakeyama H., Akita H., Maruyama K., Suhara T., Harashima H. Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo. Int J Pharm 2004, 281:25-33.
28. Bloemen P.G., Henricks P.A., van Bloois L., van den Tweel M.C., Bloem A.C., Nijkamp F.P., et al. Adhesion molecules: a new target for immunoliposome-mediated drug delivery. FEBS Lett 1995, 357:140-144.
29. Weller G.E., Lu E., Csikari M.M., Klibanov A.L., Fischer D., Wagner W.R., et al. Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1. Circulation 2003, 108:218-224.
30. Chittasupho C., Xie S.X., Baoum A., Yakovleva T., Siahaan T.J., Berkland C.J. ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. Eur J Pharm Sci 2009, 37:141-150.
31. Muro S., Wiewrodt R., Thomas A., Koniaris L., Albelda S.M., Muzykantov V.R., et al. A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. J Cell Sci 2003, 116:1599-1609.
32. Muro S., Garnacho C., Champion J.A., Leferovich J., Gajewski C., Schuchman E.H., et al. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol Ther 2008, 16:1450-1458.
33. Jefferies W.A., Brandon M.R., Hunt S.V., Williams A.F., Gatter K.C., Mason D.Y. Transferrin receptor on endothelium of brain capillaries. Nature 1984, 312:162-163.
34. Dautry-Varsat A. Receptor-mediated endocytosis: the intracellular journey of transferrin and its receptor. Biochimie 1986, 68:375-381.
35. Marlin S.D., Springer T.A. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 1987, 51:813-819.
36. Muro S. Intercellular adhesion molecule-1 and vascular cell adhesion molecule-1. Endothelial biomedicine 2007, 1058-1070. Cambridge University Press, New York. W. Aird (Ed.).
37. Ghaffarian R., Bhowmick T., Muro S. Transport of nanocarriers across gastrointestinal epithelial cells by a new transcellular route induced by targeting ICAM-1. J Control Release 2012, 163:25-33.
38. He X., Miranda S.R., Xiong X., Dagan A., Gatt S., Schuchman E.H. Characterization of human acid sphingomyelinase purified from the media of overexpressing chinese hamster ovary cells. Biochim Biophys Acta 1999, 1432:251-264.
39. Papademetriou J, Garnacho C, Serrano D, Bhowmick T, Schuchman EH, Muro S. Comparative binding, endocytosis, and biodistribution of antibodies and antibody-coated carriers for targeted delivery of lysosomal enzymes to ICAM-1 versus transferrin receptor. J Inherit Metab Dis, 2012, doi:10.1007/s10545-012-9534-6.
40. Garlanda C., Parravicini C., Sironi M., De Rossi M., Wainstok de Calmanovici R., Carozzi F., et al. Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle-sized T antigen: implications for the pathogenesis of opportunistic vascular tumors. Proc Natl Acad Sci U S A 1994, 91:7291-7295.
41. Hsu J., Serrano D., Bhowmick T., Kumar K., Shen Y., Kuo Y.C., et al. Enhanced endothelial delivery and biochemical effects of alpha-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease. J Control Release 2011, 149:323-331.
42. Bjorn M.J., Groetsema G. Immunotoxins to the murine transferrin receptor: intracavitary therapy of mice bearing syngeneic peritoneal tumors. Cancer Res 1987, 47:6639-6645.
43. Panaccio M., Zalcberg J.R., Thompson C.H., Leyden M.J., Sullivan J.R., Lichtenstein M., et al. Heterogeneity of the human transferrin receptor and use of anti-transferrin receptor antibodies to detect tumours in vivo. Immunol Cell Biol 1987, 65(Pt 6):461-472.
44. Takahashi S., Esserman L., Levy R. An epitope on the transferrin receptor preferentially exposed during tumor progression in human lymphoma is close to the ligand binding site. Blood 1991, 77:826-832.
45. van Driel I.R., Goding J.W. Heterogeneous glycosylation of murine transferrin receptor subunits. Eur J Biochem 1985, 149:543-548.
46. Muro S., Dziubla T., Qiu W., Leferovich J., Cui X., Berk E., et al. Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1. J Pharmacol Exp Ther 2006, 317:1161-1169.
47. Grill J., Van Beusechem V.W., Van Der Valk P., Dirven C.M., Leonhart A., Pherai D.S., et al. Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids. Clin Cancer Res 2001, 7:641-650.
48. Willmann J.K., Lutz A.M., Paulmurugan R., Patel M.R., Chu P., Rosenberg J., et al. Dual-targeted contrast agent for us assessment of tumor angiogenesis in vivo. Radiology 2008, 248:936-944.
49. Xu Q, Liu Y, Su S, Li W, Chen C, Wu Y. Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic rgd and transferrin conjugated hyperbranched copolymer nanoparticles. Biomaterials;33:1627-39.
50. Yan H, Wang L, Wang J, Weng X, Lei H, Wang X, et al. Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier. ACS Nano;6:410-20.
51. Markoutsa E, Papadia K, Clemente C, Flores O, Antimisiaris SG. Anti-Aβ-MAb and dually decorated nanoliposomes: effect of Aβ1-42 peptides on interaction with hCMEC/D3 cells. Eur J Pharm Biopharm;81:49-56.
52. Saul J.M., Annapragada A.V., Bellamkonda R.V. A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers. J Control Release 2006, 114:277-287.
53. Li X, Zhou H, Yang L, Du G, Pai-Panandiker AS, Huang X, et al. Enhancement of cell recognition in vitro by dual-ligand cancer targeting gold nanoparticles. Biomaterials;32:2540-5.
54. Garnacho C., Dhami R., Simone E., Dziubla T., Leferovich J., Schuchman E.H., et al. Delivery of acid sphingomyelinase in normal and Niemann-Pick disease mice using intercellular adhesion molecule-1-targeted polymer nanocarriers. J Pharmacol Exp Ther 2008, 325:400-408.
55. Henninger D.D., Panes J., Eppihimer M., Russell J., Gerritsen M., Anderson D.C., et al. Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J Immunol 1997, 158:1825-1832.